Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Analysis of Bronchiectasis in Alpha-1 Antitrypsin Deficiency.

Canadian respiratory journal·2026
Same author

Association between mental health and chronic obstructive pulmonary disease (COPD) outcomes: systematic review and meta-analysis.

BMJ open respiratory research·2026
Same author

The Role of Alpha-1 Antitrypsin in the Pathophysiology and Treatment of Inflammatory Lung Diseases.

Journal of inflammation research·2026
Same author

Integrated healthcare services for non-COPD chronic respiratory diseases: a systematic review.

BJGP open·2026
Same author

Within-individual variation of spirometry measurements in primary care: a retrospective cohort study.

BMJ open respiratory research·2026
Same author

Pulmonary Function Decline in Alpha-1 Antitrypsin Deficiency: A Systematic Review and Meta-Analysis.

International journal of chronic obstructive pulmonary disease·2026
Same journal

Impact of the Angiotensin-Converting Enzyme (ACE) Inhibitors on the Course of the Acute Respiratory Distress Syndrome (ARDS) Developed During COVID-19 and Other Severe Respiratory Infections Under Hyperferritinemia Conditions: A Cohort Study.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine·2023
Same journal

Tissue Factor and Vascular Endothelial Growth Factor in Detecting Thromboembolic Complications in Diabetic Atherosclerotic Patients.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine·2023
Same journal

Diaphragmatic Dynamics and Thickness Parameters Assessed by Ultrasonography Predict Extubation Success in Critically Ill Patients.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine·2023
Same journal

Impact of an Early Warning System Protocol, for Patients Admitted to the Medical Floors with SARS-COV2 Pneumonia, on ICU Admission.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine·2023
Same journal

Pseudo-Kussmaul's Sign in Atrioventricular Nodal Reentry Tachycardia: A Prospective, Cohort Study.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine·2023
Same journal

The Role of Early Warning Scoring Systems NEWS and MEWS in the Acute Exacerbation of COPD.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine·2023
See all related articles

Related Experiment Video

Updated: May 11, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
03:25

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease

Published on: December 27, 2024

Pharmacotherapies for COPD.

Stan Ejiofor1, Alice M Turner

  • 1Russells Hall Hospital, Dudley, West Midlands, UK.

Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
|May 24, 2013
PubMed
Summary
This summary is machine-generated.

This review covers major chronic obstructive pulmonary disease (COPD) treatments, including inhaled medications, oxygen, and smoking cessation aids. It details their mechanisms, clinical trial evidence, and compares them against global treatment guidelines.

Keywords:
chronic obstructive pulmonary diseasedisease managementpharmacotherapies

Related Experiment Videos

Last Updated: May 11, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
03:25

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease

Published on: December 27, 2024

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by persistent respiratory symptoms and airflow limitation.
  • Effective management of COPD relies on a comprehensive understanding of available therapeutic options.

Purpose of the Study:

  • To review the primary treatments for COPD, including their mechanisms of action.
  • To summarize key evidence from clinical trials supporting these treatments.
  • To compare the role of different drug classes within current international COPD guidelines.

Main Methods:

  • Systematic review of pharmacological and non-pharmacological interventions for COPD.
  • Analysis of drug classes: short-acting beta-agonists (SABA), short-acting muscarinic antagonists (SAMA), long-acting beta-agonists (LABA), long-acting antimuscarinics (LAMA), inhaled corticosteroids (ICS), and combinations.
  • Inclusion of phosphodiesterase-4 (PDE4) inhibitors, mucolytics, oxygen therapy, opiates for dyspnea relief, and smoking cessation therapies.
  • Comparison of treatment approaches based on reported clinical trial outcomes and current global guidelines.

Main Results:

  • Detailed description of mechanisms of action for SABA, SAMA, LABA, LAMA, ICS, PDE4 inhibitors, mucolytics, and oxygen.
  • Summary of pivotal clinical trial data demonstrating efficacy and safety for each drug class.
  • Comparative analysis of available agents within each class.
  • Discussion on the integration of these therapies into established COPD management strategies.

Conclusions:

  • Current COPD treatment involves a stepwise approach utilizing bronchodilators (SABA, SAMA, LABA, LAMA), inhaled corticosteroids, and other agents based on disease severity and phenotype.
  • Evidence supports the use of specific drug classes for symptom control, exacerbation reduction, and improved quality of life in COPD patients.
  • Adherence to international guidelines ensures optimal patient care by selecting appropriate therapies and considering individual patient needs.